Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
AMPRONIX
TERARECON, INC.

Preoperative Ultrasound Used to Avoid Missing Metastases in Differentiated Thyroid Cancer

By Medimaging International staff writers
Posted on 31 Oct 2013
Ultrasound imaging is typically used to identify and assess patients with differentiated thyroid cancer (DTC), and to determine whether the disease has metastasized to lymph nodes in the neck that should be taken out at the time of thyroidectomy. A retrospective review of cases covering more than 12 years found that nearly one-third of patients with DTC and neck metastases would not have had adequate surgical procedures if the surgeons had relied on pre-referral imaging studies and had not performed ultrasound themselves.

A team of researchers from the Cleveland Clinic Foundation (OH, USA) presented these new findings at the 83rd annual meeting of the American Thyroid Association, October 16-20, 2013, held in San Juan (Puerto Rico). The study was presented by Dr. Kevin Parrack, and offered several major findings. Preoperative ultrasound performed by a surgeon detected affected lymph nodes that could not be felt on physical exam and were not identified on earlier imaging scans performed by a radiologist in 31% of instances. Earlier imaging tests performed by radiology could have included ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI).

Among the patients who had radiologist-performed ultrasound specifically before being referred to an endocrine surgeon, 35% had nonpalpable cancerous lymph nodes detected on clinician-performed ultrasound. The discovery that the cancer had spread beyond the thyroid gland altered the surgical plan and allowed for removal of the affected lymph nodes at the time of the thyroidectomy.

“Ultrasound prior to thyroidectomy is an important tool for planning surgery, in that it can delineate local extent of tumor and likely nodal metastases better than physical exam and alternative imaging modalities,” said Julie Ann Sosa, MD, program committee co-chair; professor of surgery and medicine; chief, section of endocrine surgery; and director of health services research, department of surgery, Duke University School of Medicine (Durham, NC, USA). “Different providers can perform the ultrasound and neck mapping, including surgeons, radiologists, endocrinologists, and pathologists. These data are significant in that they suggest the surgeon is uniquely positioned to perform ultrasound in a way that it affords critical information that would not otherwise be available for optimizing surgical approach.”

Related Links:

Cleveland Clinic Foundation



RTI ELECTRONICS AB
SuperSonic Imagine
RADCAL

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

MRI

view channel

Use of Breast MRI Offers Optimized Care

Magnetic resonance imaging (MRI) is being used increasingly for breast cancer screening, diagnostic assessment, treatment planning, and monitoring; however, a recent study revealed that over time, the indication for breast MRI has changed. Much of the increase was found among women with breast cancer risk factors, but there... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.